Andere Sprachen

13.01. Nxera Pharma to Receive $3.6 Million Milestone Payment From Centessa
11.01. Certain Options of Centessa Pharmaceuticals plc are subject to a Lock-Up Agreement Ending on 11-JAN-2026.
11.01. Certain Restricted Share Units of Centessa Pharmaceuticals plc are subject to a Lock-Up Agreement Ending on 11-JAN-2026.
11.01. 134,421,149 Ordinary Shares of Centessa Pharmaceuticals plc are subject to a Lock-Up Agreement Ending on 11-JAN-2026.
11.01. Certain American Depositary Shares of Centessa Pharmaceuticals plc are subject to a Lock-Up Agreement Ending on 11-JAN-2026.
11.12. Centessa Pharmaceuticals plc appoints Mario Alberto Accardi as CEO
11.12. Centessa Pharmaceuticals Names Mario Alberto Accardi CEO
11.12. Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications 
11.12. Centessa Pharmaceuticals plc Announces CEO Changes, Effective January 1, 2026
11.12. Centessa Pharmaceuticals plc Announces Board Changes, Effective January 1, 2026
10.12. Sector Update: Health Care Stocks Climb Late Afternoon
10.12. Sector Update: Health Care Stocks Advance in Afternoon Trading
10.12. Centessa Set to Redefine Narcolepsy Treatment, Oppenheimer Says
02.12. Centessa Pharmaceuticals : December 2025 Corporate Overview (304466)
18.11. Centessa Pharmaceuticals Insider Sold Shares Worth $1,120,000, According to a Recent SEC Filing
17.11. Centessa Pharmaceuticals, CG Oncology Drive Q3 Biotech Momentum, Morgan Stanley Says
12.11. Sector Update: Health Care Stocks Rise Late Afternoon
12.11. Sector Update: Health Care Stocks Higher in Afternoon Trading
12.11. European Equities Close Higher in Wednesday Trading; German CPI Meets Forecasts
12.11. Centessa Pharmaceuticals Shares Rise After Pricing $250 Million American Depositary Share Offering
12.11. European Equities Traded in the US as American Depositary Receipts Rise Wednesday
12.11. Centessa Pharmaceuticals Prices $250 Million American Depositary Share Offering
12.11. Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares
11.11. Centessa Pharmaceuticals Plans ADS Offering
11.11. Centessa Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares
Keine Ergebnisse zu dieser Suche